Studies of Neuregulin/ERBB Signaling in Human Heart
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorDouglas B. Sawyer
About this trial
This study examines the role of the epidermal growth factor (EGF) receptor family and the EGF family of ligands in the regulation of non-myocytes isolated from the human heart.
Eligibility criteria
Qualifiers
Clinical diagnosis of severe coronary artery disease scheduled to undergo coronary artery bypass surgery.
Disqualifiers
less than 18 years of age
unwilling or unable to provide informed consent
known active myocarditis
hypertrophic cardiomyopathy
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov